Signaling Pathways - 15-lipoxygenases - Glucagon Receptors - Hydroxylases - ErbB
清除全部
-
B4751 L-MimosineTarget: HydroxylasesSummary: 铁螯合剂和脯氨酰-4-羟化酶抑制剂 -
B1543 Mubritinib (TAK 165)中文名: 木利替尼Target: ErbBSummary: HER2/ErbB2有效抑制剂 -
A8375 AZD8931 (Sapitinib)中文名: 沙普替尼Target: EGFR|ErbBSummary: ErbB抑制剂 -
A8319 Dacomitinib (PF299804, PF299)中文名: 达克替尼Target: ErbBSummary: HER抑制剂 -
A8218 Lapatinib2 Citation中文名: 拉帕替尼Target: ErbBSummary: EGFR/HER2抑制剂 -
A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂 -
A4335 Mildronate中文名: 米屈肼Target: Hydroxylases|carnitine reabsorptionSummary: GBB羟化酶抑制剂 -
A4092 CUDC-1011 CitationTarget: Histone Deacetylases (HDACs)|EGFR|ErbBSummary: 多靶点HDAC抑制剂 -
N1831 Luteolin中文名: 木犀草素，四羟黄酮Target: AP-1|MMP|15-lipoxygenasesSummary: 抗氧化剂和自由基清除剂